Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1500 | Alvocidib | 0.0316227766017 | 1.2218 | -0.26486 |
| HCC1500 | AZD5363 | 0.1 | 1.5933 | -0.24844 |
| HCC1500 | Rucaparib | 0.001 | 0.8594 | -0.24378 |
| HCC1500 | AZD5363 | 0.316227766017 | 4.3646 | -0.24185 |
| HCC1500 | AZD5363 | 10.0 | 3.2698 | -0.24139 |
| HCC1500 | Ribociclib | 0.001 | 0.8225 | -0.24023 |
| HCC1500 | Rucaparib | 0.0316227766017 | 0.2576 | -0.23581 |
| HCC1500 | Ribociclib | 0.00316227766017 | 1.0136 | -0.23318 |
| HCC1500 | Ribociclib | 0.0316227766017 | 0.0597 | -0.23205 |
| HCC1500 | AZD6738 | 0.01 | 0.7505 | -0.23101 |
| HCC1500 | RO-3306 | 0.1 | 0.5975 | -0.23065 |
| HCC1500 | RO-3306 | 0.00316227766017 | 0.4411 | -0.23012 |
| HCC1500 | Ribociclib | 0.001 | 0.7155 | -0.22856 |
| HCC1500 | AZD5363 | 1.0 | 1.6942 | -0.22850 |
| HCC1500 | THZ531 | 0.0001 | 1.8788 | -0.22658 |
| HCC1500 | Alvocidib | 0.0316227766017 | 3.6246 | -0.22656 |
| HCC1500 | AZD5363 | 0.316227766017 | 2.2206 | -0.22546 |
| HCC1500 | Ribociclib | 0.316227766017 | 0.7505 | -0.22255 |
| HCC1500 | AZD6738 | 0.01 | 1.9060 | -0.22086 |
| HCC1500 | BMS-265246 | 10.0 | 1.2877 | -0.21982 |
| HCC1500 | AZD5363 | 0.01 | 0.8594 | -0.21940 |
| HCC1500 | Ulixertinib | 0.1 | 1.4958 | -0.21929 |
| HCC1500 | AZD6738 | 0.001 | 1.9890 | -0.21843 |
| HCC1500 | BMS-265246 | 10.0 | 1.1364 | -0.21766 |
| HCC1500 | Alvocidib | 0.000316227766017 | 3.2698 | -0.21698 |